MedTrace Logo

Health-related Quality of Life in Patients on Anticoagulants

NCT03134911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 535

Last updated 2019-04-18

Study results available
· View outcomes & findings →

Summary

The present study has been designed to describe the health-related quality of life in patients with non valvular atrial fibrillation who have been prescribed a specific anticoagulant treatment for their non valvular atrial fibrilation at least 6 months prior to study initiation. It will be conducted in Departments of Internal Medicine from approximately 50 centers in Spain. It consists of an only visit that will coincide with one of those performed by the patients as part of routine follow-up of their disease. 500 patients seen in internal medicine are planned to be included in the study

Conditions

Interventions

DRUG

DOAC or VKA

6 months - 2 years

DRUG

VKA

6 months - 2 years

Sponsors & Collaborators

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-24
Primary Completion
2018-01-31
Completion
2018-01-31
FDA Drug
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03134911 on ClinicalTrials.gov